Written by - The Preimplantation Genetic Testing Market is expanding as fertility specialists increasingly use genetic testing to evaluate embryos before implantation during assisted reproductive procedures. PGT can help identify chromosomal abnormalities and inherited genetic conditions, supporting informed embryo selection and fertility treatment planning. The market reached USD 954.0 million in 2025 and is projected to reach USD 2.43 billion by 2035, expanding at a 9.8% CAGR.
Next-generation sequencing is becoming a major technology in the market, accounting for 50.8% of the market in 2025. Advances in sequencing, laboratory automation, embryo analysis, and artificial intelligence are improving testing efficiency and supporting more detailed genetic evaluation. AI-assisted imaging is also emerging as a rapidly developing technology area.
Fertility clinics represented 63.0% of the market in 2025, reflecting the close integration of genetic testing with IVF workflows. Diagnostic laboratories, hospitals, and research institutes also contribute to demand as reproductive genetics becomes increasingly integrated into fertility and genomic services.
North America held the largest regional share at 38.6% in 2025, while Asia-Pacific is projected to register the fastest growth at 13.7% through 2035. Growing fertility clinic capacity, increasing awareness of genetic testing, and advances in non-invasive PGT are expected to support continued market development.
Explore additional reports to understand evolving market landscapes:
Radiation Protection Apparels Market Size
Radiation Protection Apparels Market Share
Radiation Protection Apparels Market Trends